Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals.

V Soriano, V Moreno-Torres, C de Mendoza… - AIDS …, 2023 - search.ebscohost.com
Viruses cause a large burden of human infectious diseases. During the past 50 years,
antivirals have been developed to treat many pathogenic viruses, including herpesviruses …

Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023)

C de Mendoza, G Taylor, A Gessain… - NeuroImmune …, 2024 - degruyter.com
The 30th workshop of the HTLV European Research Network (HERN) was held in Madrid
on September 15–16, 2023. Over fifty researchers from Europe and America convened for a …

Clinical Features and Survival Outcome in Aggressive-Type Adult T-Cell Leukemia/Lymphoma Patients: Real-Life Experience of a Single Center from an HTLV-1 …

I Iordan, AM Vlădăreanu, C Mambet, M Onisâi… - Medicina, 2024 - mdpi.com
Background and Objectives: Adult T-cell leukemia/lymphoma (ATLL) is a highly aggressive
T-cell lymphoproliferative disease associated with the human T-cell lymphotropic virus type I …

Prevalence of human T-cell lymphotropic virus-1/2 in Canada over 33 years: A unique contribution of blood donors to public health surveillance

SF O'Brien, B Ehsani-Moghaddam, M Goldman… - Canadian Journal of …, 2024 - Springer
Abstract Objectives Estimate HTLV-1/2 (human T-cell lymphotropic viruses) prevalence in
Canadian blood donors and the association of demographic variables with infection and …

Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN

C de Mendoza, G Taylor, A Gessain, AK Thoma-Kress… - degruyter.com
The 30th workshop of the HTLV European Resea rch Network (HERN) was held in Madrid
on September 15–16, 2023. Over fifty researchers from Europe and America convened for a …